Niravoline
Niravoline (pronounced: nee-rah-voh-leen) is a pharmaceutical drug used in the treatment of various medical conditions.
Etymology
The term "Niravoline" is derived from the Sanskrit word "Nirav", meaning "quiet" or "calm", and the Latin word "oline", a common suffix in pharmacology indicating a chemical compound.
Usage
Niravoline is a kappa opioid receptor agonist. It was developed in the 1990s by the pharmaceutical company Sanofi-Aventis. It was initially researched as a potential treatment for stroke and migraine, but clinical trials were halted due to concerns about its potential to cause liver damage.
Pharmacology
Niravoline works by binding to and activating kappa opioid receptors in the brain. These receptors are involved in pain perception and mood regulation. By activating these receptors, Niravoline can help to reduce pain and improve mood.
Related Terms
- Kappa Opioid Receptor: A type of opioid receptor in the brain that Niravoline binds to and activates.
- Sanofi-Aventis: The pharmaceutical company that developed Niravoline.
- Stroke: A medical condition that Niravoline was initially researched as a potential treatment for.
- Migraine: A type of headache that Niravoline was initially researched as a potential treatment for.
See Also
External links
- Medical encyclopedia article on Niravoline
- Wikipedia's article - Niravoline
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski